1. Clinical | - Interstitial
lung diseases
- CT
for pneumologists
- Clinical
problems solving
- Interventional
pulmonology
- Sarcoidosis
- Biopsy
options
- Lung
cancer screening
|
2. Respiratory intensive care | - NIV
vs. HFNC for hypoxemic patients
- Expanding
NIV indication for weaning purposes: patient populations, modes of
ventilation, interfaces, sedatives)
- Long
term mechanical ventilation in COPD: which markers should we consider?
How should we monitor? Where should we start it?
- Beyond
flow, volume and airway pressure: which signals should we consider today
for the ventilatory management of critically-ill patients
- Bedside
imaging of the critically ill patient
- Weaning
ten years later: are the statements of the Sixth International Consensus
Conference on Intensive Care Medicine about Weaning still valid?
- Non-invasive
ventilation vs. High Flow Nasal Cannula
- Hospital-acquired
and ICU-acquired pneumonia
- What
outcome for mechanically ventilated patients?
|
3. Cell and molecular biology | - Immunity
and the Lung
- The
Lung Microbiome
- Stem
Cells in Lung Diseases
- Lung
Matrix
- Emphysema
|
4. Clinical physiology, sleep and pulmonary circulation | - New
paradigms in the diagnosis of sleep apnoea
- Interaction
of sleep apnoea and respiratory failure
- Deleterious/protective
effects of intermittent hypoxia in OSA
- From
brain to cardiopulmonary interaction passing through locomotor muscles:
the origin and mechanisms of exertional dyspnoea in cardiorespiratory
diseases
- Respiratory
muscle at rest and during exercise: What's new?
- Mild
COPD: physiology, clinical implications, treatment....where are we?
- Respiratory
muscle testing: an update
|
5. Airway diseases | - Immunity
in asthma and COPD
- Eosinophili
inflammation in COPD
- Non-invasive
assessment of airway inflammation
- Pharmacological
treatment in bronchiectasis
- Personalised
medicine in airway disease
- Blood
eosinophilia in COPD
- Non-invasive
technique to assess airway inflammation
- ICS
in COPD: how, when, why
- Chronic
cough and eosinophili bronchitis
|
6. Occupation and epidemiology | - Lung
cancer screening
- Microbiota
and lung disease
- Smoking
cessation
- Statistical
methods in epidemiology
- Gene-environment
interactions and the individual patient
- Prediction
rules for asthma and COPD
- The
respiratory microbiome and the environment
- How
can we keep individuals with respiratory disease at work
|
7. Paediatrics | - Bronchiolitis
and preschool wheezing
- Asthma
- Microbioma
in respiratory infections
- Lung
Function Tests
- Non-CF bronchiectasis
and PCD
- Acute
and chronic respiratory infection
|
8. Thoracic surgery and transplantation | - Difficult
lung transplant indications
- Donors
for lung transplantation in 2017: where are we?
- Lung
transplantation and cancer
- Difficult
pulmonary infections: what have we learned from lung transplantation?
- Key
points of the preoperative selection for marginal surgical candidates
- What
is the optimal multimodality treatment for lung cancer?
- Medistinal
problems
- Mesothelioma
- Pneumothorax
- Bronchiectasis
- localised form
- Undetermined
lung nodules
|
9. Allied respiratory professionals | - Relevant
outcomes to measure in chronic disease management
- Pulmonary
rehabilitation
- New
techniques in diagnosing respiratory diseases
- Self-management
in respiratory disease
- Muscle
function and structure in COPD
- Care
models for chronic lung disease
|
10. Respiratory infections | - Pneumonia
- Antimicrobial
resistance
- New
anti-TB drugs
- Influenza
and viral infections
- New
diagnostics, including whole genome sequencing, for the TB diagnosis
- LTBI
- Challenges
in LTBI management
- Microbial
phenotypes in chronic airway diseases
- Clinical
impact of NTM
- Global
perspective on ILI
- New
and repurposed anti-TB drugs
|
11. Thoracic oncology | - Update
on immuno-therapies and its combinations with standard therapies in lung
cancer
- Rational
diagnostic work-up of lung cancer at the time of first diagnosis and
relapse – What do we need to know to treat our patients and how do we
get the needed information? - Interventional techniques
- Rational
diagnostic work-up of lung cancer at the time of first diagnosis and
relapse – What do we need to know to treat our patients and how do we
get the needed information? - Molecular pathology
- The
new TNM-staging system and beyond – predicting lung cancer prognosis
- Rational
diagnostic work-up of lung cancer at the time of first diagnosis and
relapse – What do we need to know to treat our patients and how do we
get the needed information? - Imaging techniques
- Update
on malignant pleural mesothelioma
- Early
integration of palliative care in thoracic oncology patients – has the
goal been really achieved yet?
- How
to evaluate fitness for therapy in lung cancer patients and how to
follow them up after surgery, radiotherapy and/or chemotherapy
- Early
integration of palliative care for lung cancer patients
- Deliver
bad news
- Immunotherapy
in interaction with Anti-VEGF stategies
- Therapeutic
sequences for lung cancer treatment
- Infectious
and immunological complications during lung cancer treatment
|
